Our findings are in keeping with the concept that pharmacological manipulation of peripheral TRPA1 channels may attenuate changes in blood flow and hyperalgesia associated with arthritis, particularly in cold conditions. The gene discussed is TRPA1; the disease is arthritic joint disease.